INDEPENDENT Pharmacies Australia (IPA) has announced a significant 9.1% growth based on like-for-like pharmacy sales year-on-year in 2024.
Retail sales (middle and front of shop) experienced a 6.7% increase over the same period.
IPA said the surge follows a strategic reorganisation designed to better support its network of around 1,100 member pharmacies across the country.
According to Steven Kastrinakis, Managing Director of IPA, 2024 signalled an opportunity for the organisation to provide strong support for pharmacy members within the IPA network.
"The last year has been a rewarding one for our Advantage Pharmacies, Alliance Pharmacies, Chemist Discount Centres, Pharmacy Catalyst members and other independent pharmacies that we support.
"We've worked closely with all our members to minimise the 60DD impact and seize opportunities through full scope of practice and the 8CPA strategy implementation," Kastrinakis said, adding they had outperformed the market by 3.1 percentage points in both middle-of-shop and front-of-shop categories.
The above article was sent to subscribers in Pharmacy Daily's issue from 07 Feb 25
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Feb 25
